Because depletion of BMI1 was reported to enhance the sensitivity of MM cells to bortezomib42, the cooperative effects of PTC596 and bortezomib on BMI1 protein levels might be another mechanism of the synergistic action of this combination. The gene discussed is BMI1; the disease is Miyoshi myopathy.